Investor Presentation First Nine Months of 2023 slide image

Investor Presentation First Nine Months of 2023

130 Investor presentation First nine months of 2023 GLP-1 market share and market growth in Rest of World Rest of World GLP-1 market growth and Novo Nordisk market share 150% DKK billion 160% GLP-1 market size and growth -36% 130% 110% 90% 117% 120% 8 82% 80% 4 11 0 0 70% 50% 60% 40% 70% 36% 82% -60% 30% 10% 0% Aug NN market share Aug Aug Novo Nordisk Company A Others Aug 2022 2023 2020 NN share of growth 2023 -Market growth (right axis) Novo Nordisk Competitors NN growth (right axis) Source: IQVIA, Aug 2023, Value, MAT; Due to contractual obligations competitor names are not disclosed. Company A represents an actual company. NN: Novo Nordisk; Market values are based on the list prices
View entire presentation